...
首页> 外文期刊>American Journal of Physiology >Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis
【24h】

Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis

机译:血红蛋白的亚硝酸盐还原酶活性作为系统性一氧化氮生成器机制解毒溶血过程中产生的血浆血红蛋白

获取原文
获取原文并翻译 | 示例

摘要

First published June 13, 2008; doi:10.1I52/ajpheart.00151.2008.-Hemoglobin (Hb) potently inactivates the nitric oxide (NO) radical via a dioxygenation reaction forming nitrate (NO~). This inactivation produces endothelial dysfunction during hemolytic conditions and may contribute to the vascular complications of Hb-based blood substitutes. Hb also functions as a nitrite (NO~) reductase, converting nitrite into NO as it deoxygenates. We hypothesized that during intravascular hemolysis, nitrite infusions would limit the vasoconstrictive properties of plasma Hb. In a canine model of low- and high-intensity hypotonic intravascular hemolysis, we characterized hemodynamic responses to nitrite infusions. Hemolysis increased systemic and pulmonary arterial pressures and systemic vascular resistance. Hemolysis also inhibited NO-dependent pulmonary and systemic vasodilation by the NO donor sodium nitroprusside. Compared with nitroprusside, nitrite demonstrated unique effects by not only inhibiting hemolysis-associated vasoconstriction but also by potentiating vasodilation at plasma Hb concentrations of <25 mul. We also observed an interaction between plasma Hb levels and nitrite to augment nitroprusside-induced vasodilation of the pulmonary and systemic circulation. This nitrite reductase activity of Hb in vivo was recapitulated in vitro using a mitochondrial NO sensor system. Nitrite infusions may promote NO generation from Hb while maintaining oxygen delivery; this effect could be harnessed to treat hemolytic conditions and to detoxify Hb-based blood substitutes.
机译:首次发布于2008年6月13日; doi:10.1I52 / ajpheart.00151.2008.-血红蛋白(Hb)通过双加氧反应有效地使一氧化氮(NO)自由基失活,形成硝酸盐(NO〜)。这种失活会在溶血条件下产生内皮功能障碍,并可能导致基于Hb的血液替代品的血管并发症。血红蛋白还起亚硝酸盐(NO〜)还原酶的作用,在其脱氧时将亚硝酸盐转化为NO。我们假设在血管内溶血期间,亚硝酸盐输注会限制血浆血红蛋白的血管收缩特性。在低强度和高强度低渗性血管内溶血的犬模型中,我们表征了对亚硝酸盐输注的血液动力学反应。溶血会增加全身和肺动脉压力以及全身血管阻力。溶血还通过NO供体硝普钠抑制NO依赖性肺和全身血管舒张。与硝普钠相比,亚硝酸盐不仅通过抑制溶血相关的血管收缩,而且在血浆Hb浓度<25 mul时通过增强血管舒张作用而显示出独特的作用。我们还观察到血浆血红蛋白水平与亚硝酸盐之间的相互作用,以增加硝普钠诱导的肺循环和全身循环的血管舒张。使用线粒体NO传感器系统在体外概括了Hb在体内的亚硝酸还原酶活性。注入亚硝酸盐可促进Hb生成NO,同时保持氧气的输送。可以利用这种作用来治疗溶血性疾病并为基于Hb的血液替代品排毒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号